Prevalence of hyperhomocysteinemia in china: A systematic review and meta-analysis

Nutrients

Volumn 7, Issue 1, 2015, Pages 74-90

  Yang, Boyi ^a   Fan, Shujun ^a   Zhi, Xueyuan ^a   Wang, Yinuo ^b   Wang, Yanxun ^b   Zheng, Quanmei ^a   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shanghai Institute of Targeted Therapy and Molecular Medicine   (China)

Author keywords

China; Hyperhomocysteinemia; Meta analysis; Prevalence

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

AGE; ARTICLE; CHEMICAL ANALYSIS; CHEMILUMINESCENCE IMMUNOASSAY; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; LIFESTYLE MODIFICATION; META ANALYSIS; PREVALENCE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TURBIDIMETRY; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; FACTUAL DATABASE; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; DATABASES, FACTUAL; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84920090349     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7010074     Document Type: Article

References (53)

1. Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002, 325, doi:10.1136/bmj.325.7374.1202.
2. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002, 288, 2015–2022.
3. De Ruijter, W.; Westendorp, R.G.; Assendelft, W.J.; den Elzen, W.P.; de Crean, A.J.; le Cessies, S.; Gussekloo, J. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: Population based observational cohort study. BMJ 2009, 8, doi:10.1136/bmj.a3083.
4. Brustolin, S.; Giugliani, R.; Felix, T.M. Genetics of homocysteine metabolism and associated disorders. Braz. J. Med. Biol. Res. 2010, 43, 1–7.
5. Yakub, M.; Schulze, K.J.; Khatry, S.K.; Stewart, C.P.; Christian, P., Jr.; West, K.P. High plasma homocysteine increases risk of metabolic syndrome in 6 to 8 year old children in rural Nepal. Nutrients 2014, 6, 1649–1661.
6. Refsum, H.; Ueland, P.M.; Nygard, O.; Vollset, S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 1998, 49, 31–62.
7. Nygard, O.; Vollset, S.E.; Refsum, H.; Brattstrom, L.; Ueland, P.M. Total homocysteine and cardiovascular disease. J. Intern. Med. 1999, 246, 425–454.
8. Schafer, J.H.; Glass, T.A.; Bressler, J.; Todd, A.C.; Schwartz, B.S. Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ. Helath Prespect. 2005, 1, 31–35.
9. Refsum, H.; Nurk, E.; Smith, A.D.; Ueland, P.M.; Gjesdal, C.G.; Bjelland, I.; Tverdal, A.; Tell, G.S.; Nygard, O.; Vollset, S.E. The Hordaland Homocysteine Study: A community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 2006, 136, 1731–1740.
10. Carmel, R.; Green, R.; Jacobsen, D.W.; Rasmussen, K.; Fbrea, M.; Azen, C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in cobalamin and metabolite abnormalities. Am. J. Clin. Nutr. 1999, 70, 904–910.
11. Amouzou, E.K.; Chabi, N.W.; Adjalla, C.E.; Rodriguez-Gueant, R.M.; Feillet, F.; Villaume, C.; Sanni, A.; Gueant, J.L. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C→T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am. J. Clin. Nutr. 2004, 79, 619–624.
12. Hao, L.; Ma, J.; Stampfer, M.J.; Ren, A.; Tian, Y.; Willett, W.C.; Li, Z. Geographical, seasonal and gender differences in folate status among Chinese adults. J. Nutr. 2003, 133, 3630–3635.
13. Yang, B.; Liu, Y.; Li, Y.; Fan, S.; Zhi, X.; Lu, X.; Wang, D.; Zheng, Q.; Wang, Y.; Wang, Y.; et al. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G Gene polymorphisms in China: Findings from 15357 adults of Han nationality. PLoS One 2013, 8, doi:10.1371/journal.pone.0057917.
14. Wang, Y.F.; Pei, L.J.; Wang, J.F.; Zheng, X.Y. Is the prevalence of MTHFR C677T polymorphism associated with ultraviolet radiation in Eurasia? J. Hum. Genet. 2012, 57, 780–786
15. The World Bank. Toward a Healthy and Harmonious Life in China: Stemming the Rising Tide of Non-Communicable Disease. Available online: http://www.worldbank.org/en/news/feature/2011/07/26/toward-health-harmonious-life-china-stemming-rising-tide-of-non-communicable-diseases (accessed on 4 September 2014).
16. Ministry of Health of the People’s Republic of China. China Birth Defects Prevention Report (2012). Available online: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohfybjysqwss/s7901/201209/55840.htm (accessed on 4 September 2014).
17. Li, X.H.; Zhu, J.; Wang, Y.P.; Mu, D.Z.; Zhou, G.X.; Li, Q. Geographic and urban-rural disparities in the total prevalence of neural tube defects and their subtypes during 2006–2008 in China: A study using the hospital-based birth defects surveillance system. BMC Public Health 2013, 13, doi:10.1186/1471-2458-13-161.
18. Zintzaras, E.; Ioannidis, J.P. Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 2005, 28, 123–137.
19. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986, 7, 177–188.
20. Thompson, S.G.; Sharp, S.J. Explaining heterogeneity in meta-analysis: A comparison of methods. Stat. Med. 1999, 18, 2693–2708.
21. Mickey, R.M.; Greenland, S. The impact of confounder selection criteria on effect estimation. Am. J. Epidemiol. 1989, 129, 125–137.
22. Trikalinos, T.A.; Salanti, G.; Zintzaras, E. Meta-analysis methods. Adv. Genet. 2008, 60, 311–334.
23. Egger, M.; Davey, S.G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629–634.
24. Mello, A.L.; Cunha, S.F.; Foss-Freitas, M.C.; Vannucchi, H. Evaluation of plasma homocysteine level according to the C677T and A1298C polymorphism of the enzyme MTHFR in type 2 diabetic adults. Arq. Bras. Endocrinol. Metab. 2012, 56, 428–434.
25. Mahfouz, R.A.; Cortas, N.K.; Charafeddine, K.M.; Abdul Khalik, R.N.; Sarieddine, D.S.; Kadi, R.H. Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults. Gene 2012, 504, 175–180.
26. Marti, F.; Vollenweider, P.; Marques-Vidal, P.M.; Mooser, V.; Weaber, G.; Paccaud, F.; Bochud, M. Hyperhomocysteinemia is independently associated with albuminuria in the population-based Colaus study. BMC Public Health 2011, 11, doi:10.1186/1471-2458-11-733.
27. Kim, M.K.; Ordovas, J.M.; Selhub, J.; Campos, H. B vitamins and plasma homocysteine concentrations in an urban and rural area of Costa Rica. J. Am. Coll. Nutr. 2003, 22, 224–231.
28. Moon, H.W.; Whang, D.H.; Ko, Y.J.; Joo, S.Y.; Yun, Y.M.; Hur, M.; Kim, J.Q. Reference interval and determinants of the serum homocysteine level in a Korean population. J. Clin. Lab. Anal. 2011, 5, 317–323.
29. Fakhrzadeh, H.; Ghotbi, S.; Pourebrahim, R.; Nouri, M.; Heshmat, R.; Bandarian, F.; Shafaee, A.; Larijani, B. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: The Tehran homocysteine survey (2003–2004)/A cross-sectional population based study. BMC Public Health 2006, 6, doi:10.1186/1471-2458-6-29.
30. Hambaba, L.; Abdessemed, S.; Yahia, M.; Laroui, S.; Rouabah, F. Relationship between hyperhomocysteinemia and C677T polymorphism of methylenetetrahydrofolate reductase gene in a healthy Algerian population. Ann. Biol. Clin. (Paris) 2008, 66, 637–641.
31. Jacques, P.F.; Selhub, J.; Bostom, A.G.; Wilson, P.W.; Rosenberg, I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med. 1999, 340, 1449–1454.
32. Hickling, S.; Hung, J.; Knuiman, M.; Jamrozik, K.; McQuilan, B.; Beilby, J.; Thompson, P. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: A population based cohort study. J. Epidemiol. Community Health 2005, 59, 371–376.
33. Berry, R.J.; Li, Z.; Erickson, J.D.; Li, S.; Moore, C.A.; Wang, H.; Mulinare, J.; Zhao, P.; Wong, L.Y.; Gindler, J.; et al. Prevention of neural-tube defects with folic acid in China: China-U.S. Collaborative Project for Neural Tube Defect Prevetion. N. Engl. J. Med. 1999, 20, 1485–1490.
34. Debreceni, B.; Debreceni, L. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovasc. Ther. 2014, 3, 130–138.
35. Rautiainen, S.; Akesson, A.; Levitan, E.B.; Morgenstern, R.; Mittleman, M.A.; Wolk, A. Multivitamin use and the risk of myocardial infarction: A population-based cohort of Swedish women. Am. J. Clin. Nutr. 2010, 5, 1251–1256.
36. Ji, Y.; Tan, S.; Xu, Y.; Chandra, A.; Shi, C.; Song, B.; Qin, J.; Gao, Y. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: A meta-analysis. Neurology 2013, 15, 1298–1307.
37. Qin, X.; Huo, Y.; Lanqman, C.B.; Hou, F.; Chen, Y.; Matossian, D.; Xu, X.; Wang, X. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: A meta-analysis. Clin. J. Am. Soc. Nephrol. 2011, 3, 482–488.
38. Ebbing, M.; Bonna, K.H.; Nygard, O.; Arnesen, E.; Ueland, P.M.; Nordrehaug, J.K.; Rasmussen, K.; Njolstad, I.; Refsum, H.; Nilsen, D.W.; et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009, 19, 2119–2126.
39. Qin, X.; Cui, Y.; Shen, L.; Sun, N.; Zhang, Y.; Li, J.; Xu, X.; Wang, B.; Xu, X.; Huo, Y.; et al. Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. Int. J. Cancer 2013, 5, 1033–1041.
40. Chen, P.; Li, C.; Li, X.; Li, J.; Chu, R.; Wang, H. Higher dietary folate intake reduces the breast cancer risk: A systematic review and meta-analysis. Br. J. Cancer 2014, 9, 2327–2338.
41. Lin, H.L.; An, Q.Z.; Wang, Q.Z.; Liu C.X. Folate intake and pancreatic cancer risk: An overall and dose-response meta-analysis. Public Health 2013, 7, 607–613.
42. Dai, W.M.; Yang, B.; Chu, X.Y.; Wang, Y.Q.; Zhao, M.; Chen, L.; Zhang, G.Q. Association between folate intake, serum folate levels and the risk of lung cancer: A systematic review and meta-analysis. Chin. Med. J. (Engl.) 2013, 10, 1957–1964.
43. Wang, Y.; Li, X.; Qin, X.; Cai, Y.; He, M.; Sun, L.; Li, J.; Zhang, Y.; Tang, G.; Wang, B.; et al. Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45–75 years. Br. J. Nutr. 2013, 109, 1284–1293.
44. Craig, S.A. Betaine in human nutrition. Am. J. Clin. Nutr. 2004, 80, 539–549.
45. Vogiatzoglou, A.; Smith, A.D.; Nurk, E.; Berstad, D.; Drevon, C.A.; Ueland, P.M.; Vollset, S.E.; Tell, G.S.; Refsum, H. Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: The Hordaland Homocysteine Study. Am. J. Clin. Nutr. 2009, 89, 1078–1087.
46. Jacques, P.F.; Rosenberg, I.H.; Rogers, G.; Selhub, J.; Bowman, B.A.; Gunter, E.W.; Wright, J.D.; Johnson, C.L. Serum total homocysteine concentrations in adolescent and adult Americans: Results from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 1999, 69, 482–489.
47. Refsum, H.; Smith, A.D.; Ueland, P.M.; Nexo, E.; Clarke, R.; Mcpartlin, J.; Johnson, C.; Enqbeak, F.; Schneede, J.; McPartlin, C.; et al. Facts and recommendations about total homocysteine determinations: An expert opinion. Clin. Chem. 2004, 50, 3–32.
48. Brattstrom, L.; Lindgren, A.; Israelsson, B.; Andersson, A.; Hultberg, B. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 1994, 236, 633–641.
49. Rauh, M.; Verwied, S.; Knerr, I.; Dorr, H.G.; Sonnichsen, A.; Koletzko, B. Homocysteine concentrations in a German cohort of 500 individuals: Reference ranges and determinants of plasma levels in healthy children and their parents. Amino Acids 2001, 20, 409–418.
50. Giltay, E.J.; Hoogeveen, E.K.; Elbers, J.M.; Gooren, L.J.; Asscheman, H.; Stehouwer, C.D. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females. J. Clin. Endocrinol. Metab. 1998, 83, 550–553.
51. Mijatovic, V.; Kenemans, P.; Jakobs, C.; van Baal, W.M.; Peter-Muller, E.R.; vander Mooren, M.J. A randomized controlled study of the effects of 17 beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet. Gynecol. 1998, 91, 432–436.
52. Guttormsen, A.B.; Ueland, P.M.; Svarstad, E.; Refsum, H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney. Int. 1997, 52, 495–502.
53. Selhub, J.; Jacques, P.F.; Wilson, P.W.; Rush, D.; Rosenberg, I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270, 2693–2698.